News & Events

Upcoming events

News

Report
24 July 2019

RSNN responds to EMA’s draft strategy ‘Regulatory Science to 2025’

The RSNN is very excited about the draft strategy and foresees significant contributions to innovating and improving regulatory science.

Read more
Newsletter
16 July 2019

RSNN Newsletter 7: July 2019

In the seventh edition, we look at events and publications in 2019. Scroll down for regulatory science news, reports and upcoming events. We share insights...

Read more
Report
15 July 2019

Innovating clinical trials: a rich menu of options in which early dialogue will identify acceptable and feasible approaches

RSNN – Workshop 2019 – Key Takeaways

Read more
Publication
16 May 2019

Regulation is too important to leave it to the regulators

Last month, professor Bert Leufkens published an editorial in the British Journal of Clinical Pharmacology.

Read more
Interview
22 March 2019

A welcome to Marjon Pasmooij

It’s good to welcome Marjon Pasmooij as the latest member of the RSNN Steering Committee. We asked her to discuss how she sees the role of RSNN, and what...

Read more
15 March 2019

Regulatory Science Magazine 7: advanced therapies and regulatory science in 2025

The MEB, the Dutch medicines authority, publishes the seventh edition of its Regulatory Science Magazine today. This edition focuses on the MEB science day...

Read more
08 March 2019

Looking back and looking forward

In 2018, RSNN further expanded its network and activities. 2019 promises to be an exciting year in which RSNN activities will expand further, with an...

Read more
Newsletter
27 December 2018

RSNN Newsletter 6: December 2018

With the sixth edition of the RSNN newsletter, a new look is introduced. In this edition, we report on the RSNN sessions during the FIGON Dutch Medicines...

Read more
Interview
13 December 2018

A forum for discussion: "The emergence of regulatory science gave us the opportunity to reach out to others"

Christine Gispen-de Wied is stepping down as Vice-Chair of the RSNN, after three years in the role. She shared her thoughts on what regulatory science has...

Read more
Report
28 November 2018

Regulatory challenges for the next wave of cancer therapies

In the RSNN morning session of the FIGON Dutch Medicines Days speakers from different perspectives presented their views on the challenges that come with...

Read more
Report
28 November 2018

Evidence generation for innovative products in oncology

In the RSNN afternoon session of the FIGON Dutch Medicines Days, future evidence generation strategies were discussed.

Read more
28 November 2018

Focus on paediatric medicines in 6th edition of MEB’s Regulatory Science Magazine

Last week, the Medicines Evaluation Board (MEB) launched its 6th edition of the Regulatory Science Magazine.

Read more

Pages